rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Sandra Isabelle Barros Alves

SVP, Finance and CAO

Company insider

Files Form 4 as: SVP, Finance and CAO, Repare Therapeutics.

In numbers

Trades disclosed
8
Buys
0
Sells
0
Bought
$0
Sold
$0
Companies
1
Companies where not an officer
0
First trade
2 Apr 2025
Last trade
28 Jan 2026
Last filed
28 Jan 2026

Companies traded

Where they are an officer
Repare TherapeuticsOfficer · Biotechnology · last 28 Jan 20260 buys · 0 sells

Activity over time

Not enough dated trades to draw.

Every trade

TradedCompanyWhatAmount
28 Jan 2026filed 28 Jan 2026Repare TherapeuticsBiotechnologySEC FORM 4 Code D—31,622filing
28 Jan 2026filed 28 Jan 2026Repare Therapeuticsoption or derivative · BiotechnologySEC FORM 4 Code D—26,000 at $0.00filing
28 Jan 2026filed 28 Jan 2026Repare Therapeuticsoption or derivative · BiotechnologySEC FORM 4 Code D—24,500 at $0.00filing
28 Jan 2026filed 28 Jan 2026Repare Therapeuticsoption or derivativeSEC FORM 4 Code D—26,000 at $0.00filing
28 Jan 2026filed 28 Jan 2026Repare Therapeuticsoption or derivativeSEC FORM 4 Code D—24,500 at $0.00filing
28 Jan 2026filed 28 Jan 2026Repare TherapeuticsSEC FORM 4 Code D—31,622filing
2 Apr 2025filed 29 Apr 2025Repare Therapeuticsoption or derivativeSEC FORM 4 Code A—24,500 at $0.00filing
2 Apr 2025filed 29 Apr 2025Repare TherapeuticsSEC FORM 4 Code A—4,100 at $0.00filing

News

No headline names them, or the companies they trade most, lately.

Sectors

No trade we could place in a sector.

Related people

BVF PARTNERS L P/ILDirector and Other role · 10% owner at Repare Therapeutics, filing Form 4 there in the last year
Ann D. RhoadsDirector · Director at Repare Therapeutics, filing Form 4 there in the last year
Carol SchaferDirector · Director at Repare Therapeutics, filing Form 4 there in the last year
Thomas CivikCEO & Chairman of the Board · Director at Repare Therapeutics, filing Form 4 there in the last year
Steve ForteEVP, Chief Financial Officer · EVP, Chief Financial Officer at Repare Therapeutics, filing Form 4 there in the last year